Birinci Basamakta Jinekoloji
Özet
Bu bölüm, birinci basamakta vajinitli kadına yaklaşım, menopoz dönemi ve rahim ağzı (serviks) kanseri taramasını kapsamlı bir şekilde ele almaktadır. Vajinit; enfeksiyon, inflamasyon veya vajinal floradaki bozulmalardan kaynaklanır; en sık etkenler bakteriyel vajinoz, Candida ve Trichomoniasis’tir. Değerlendirmede öykü, fizik muayene, vajinal pH ölçümü ve mikroskopi temel unsurlardır. Menopoz, 12 ay boyunca süren amenore ile tanımlanır; perimenopoz ve erken postmenopozal dönemde vazomotor semptomlar (sıcak basması), vajinal kuruluk, uyku bozuklukları ve duygudurum değişiklikleri sık görülür. Rahim ağzı kanseri taramasında Pap testi (sitoloji), HPV testi ve co-test yöntemleri kullanılır. Ortalama riskli kadınlarda 30-65 yaş arasında toplum tabanlı tarama önerilirken; 21 yaş altındaki asemptomatik bireylerde tarama yapılması tavsiye edilmez. HIV ve immünosüpresyonu olan yüksek riskli hastalar ile hysterektomi öyküsü bulunan hastaların izlemi özel kriterlere göre yönetilmelidir.
Referanslar
Sobel JD. Vulvovaginitis in healthy women. Compr Ther 1999; 25:335.
Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA 2004; 291:1368.
Landers DV, Wiesenfeld HC, Heine RP, et al. Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol 2004; 190:1004.
Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64:1.
Zemouri C, Wi TE, Kiarie J, et al. The Performance of the Vaginal Discharge Syndromic Management in Treating Vaginal and Cervical Infection: A Systematic Review and Meta- Analysis. PLoS One 2016; 11:e0163365.
Gaydos CA, Beqaj S, Schwebke JR, et al. Clinical Validation of a Test for the Diagnosis of Vaginitis. Obstet Gynecol 2017; 130:181.
Carr PL, Rothberg MB, Friedman RH, et al. “Shot-gun” versus sequential testing. Cost- effectiveness of diagnostic strategies for vaginitis. J Gen Intern Med 2005; 20:793.
Miller JM, Binnicker MJ, Campbell S, et al. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis 2018; 67:e1.
Allen- Davis JT, Beck A, Parker R, et al. Assessment of vulvovaginal complaints: accuracy of telephone triage and in- office diagnosis. Obstet Gynecol 2002; 99:18.
Sobel JD. Erosive Vulvovaginitis. Curr Infect Dis Rep 2003; 5:494.
Vaginitis in Nonpregnant Patients: ACOG Practice Bulletin, Number 215. Obstet Gynecol 2020;135:e1.
Lamont RF, Sobel JD, Akins RA, et al. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG 2011; 118:533.
Morris SR, Bristow CC, Wierzbicki MR, et al. Performance of a single- use, rapid, point- of- care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross- sectional study. Lancet Infect Dis 2021; 21:668.
Miro F, Parker SW, Aspinall LJ, et al. Origins and consequences of the elongation of the human menstrual cycle during the menopausal transition: the FREEDOM Study. J Clin Endocrinol Metab 2004; 89:4910.
Freeman EW, Sammel MD, Gracia CR, et al. Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertil Steril 2005; 83:383.
Burger HG, Hale GE, Dennerstein L, Robertson DM. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause 2008; 15:603.
Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women’s lives. Am J Med 2005; 118 Suppl 12B:14.
Freedman RR, Roehrs TA. Sleep disturbance in menopause. Menopause 2007; 14:826.
Schmidt PJ, Haq N, Rubinow DR. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry 2004; 161:2238.
Cohen LS, Soares CN, Vitonis AF, et al. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 2006; 63:385.
Sarrel PM. Ovarian hormones and vaginal blood flow: using laser Doppler velocimetry to measure effects in a clinical trial of post- menopausal women. Int J Impot Res 1998; 10 Suppl 2:S91.
Szoeke CE, Cicuttini F, Guthrie J, Dennerstein L. Self- reported arthritis and the menopause. Climacteric 2005; 8:49.
Dennerstein L, Dudley EC, Hopper JL, et al. A prospective population- based study of menopausal symptoms. Obstet Gynecol 2000; 96:351.
MacGregor EA. Menstruation, sex hormones, and migraine. Neurol Clin 1997; 15:125.
Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 2012; 97:1159.
Randolph JF Jr, Zheng H, Sowers MR, et al. Change in follicle- stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab 2011; 96:746.
Mohyi D, Tabassi K, Simon J. Differential diagnosis of hot flashes. Maturitas 1997; 27:203.
Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69.
Committee on Practice Bulletins—Gynecology. Practice Bulletin No. 168: Cervical Cancer Screening and Prevention. Obstet Gynecol 2016;128:e111. Reaffirmed 2020.
Benedet JL, Anderson GH, Matisic JP. A comprehensive program for cervical cancer detection and management. Am J Obstet Gynecol 1992;166:1254.
Peirson L, Fitzpatrick- Lewis D, Ciliska D, Warren R. Screening for cervical cancer: a systematic review and meta- analysis. Syst Rev 2013; 2:35.
Whitlock EP, Vesco KK, Eder M, et al. Liquid-based cytology and human papillomavirüs testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155:687.
Fontham ETH, Wolf AMD, Church TR, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin 2020; 70:321.
Moscicki AB, Shiboski S, Hills NK, et al. Regression of low- grade squamous intra- epithelial lesions in young women. Lancet 2004; 364:1678.
Schlecht NF, Platt RW, Duarte- Franco E, et al. Human papillomavirüs infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst 2003; 95:1336.
Szarewski A, Sasieni P. Cervical screening in adolescents- - at least do no harm. Lancet 2004; 364:1642.
US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2018; 320:674.
https://hsgm.saglik.gov.tr/tr/kanser- tarama-standartlari/serviks- kanseri- tarama- programı
White MC, Shoemaker ML, Benard VS. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening. Am J Prev Med 2017; 53:392.
Klumb EM, Araújo ML Jr, Jesus GR, et al. Is higher prevalence of cervical intraepithelial neoplasia in women with lupus due to immunosuppression? J Clin Rheumatol 2010; 16:153.
Moscicki AB, Flowers L, Huchko MJ, et al. Guidelines for Cervical Cancer Screening in Immuno-suppressed Women Without HİV Infection. J Low Genit Tract Dis 2019; 23:87.
Sirovich BE, Welch HG. Cervical cancer screening among women without a cervix. JAMA 2004;291: 2990.
Branković I, Verdonk P, Klinge I. Applying a gender lens on human papillomavirüs infection: cervical cancer screening, HPV DNA testing, and HPV vaccination. Int J Equity Health 2013; 12:14.
Kahn JA. HPV vaccination for the prevention of cervical intraepithelial neoplasia. N Engl J Med 2009; 361:271.
Saslow D, Castle PE, Cox JT, et al. American Cancer Society Guideline for human papillomavirüs (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007; 57:7.
US Food and Drug Administration. FDA News. FDA licenses new vaccine for prevention of cervical cancer and other diseases in females caused by Human Papillomavirüs. Released June 8, 2006. Availeble at: www.fda.gov/bbs/topics/NEWS/2006/ NEW01385.html (Accessed on September 20, 2007).
Giorgi Rossi P, Carozzi F, Federici A, et al. Cervical cancer screening in women vaccinated against human papillomavirüs infection: Recommendations from a consensus conference. Prev Med 2017; 98:21.